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ABSTRACT 
Surface plasmon resonance imaging (SPR) is a well-established label-free detection 
technique for real-time biomolecular interaction measurements. An integrated LOC sensing 
system with fluidic control for sample movement to specific locations on microarray 
surface in combination with SPR imaging is demonstrated by the measurements of human 
IgG and anti-IgG interactions from 24 patterned regions. 
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1. INTRODUCTION 
 Lab-on-a-chip (LOC) systems are rapidly becoming vital for the miniaturization of 
analytical techniques for various applications, such as genomics and proteomics [1]. LOC 
systems with integrated fluidic transport capability combined with SPR imaging provides a 
powerful technique to perform label-free multi-analyte interaction measurements in 
microarray formats [2]. Multi-analyte detection in microarray formats is very important in 
the field of medical diagnostics and drug discovery. The goal of this article is to develop a 
multi-analyte immunoassay based on a SPR imaging platform and integrated microfluidics 
with fluidic transport for sample addressing. 
 
2. PRINCIPLE OF SURFACE PLASMON RESONANCE IMAGING 
SPR imaging, a typical system is shown in figure 1a, is based on the excitation of 
surface plasmons of a thin metal layer (~50 nm), most commonly gold, by excitation with 
p-polarized light. With the excitation source at a certain angle of incidence the free electron 
oscillation reaches a maximum and an evanescent field is enhanced at the dielectric-gold 
interface. The amount of substance adsorbed at the surface during immobilization and 
antibody-antigen binding results in a measurable change in the surface plasmon resonance 
condition. In this case, the change in angle is measured temporally upon binding, shown 
qualitatively in the sensorgram in figure 1b. The baseline phase establishes a starting point 
before introducing the target analyte to the prepared surface. The association phase shows 
an increasing sensor response as the injected target analyte is injected and binds to the 
immobilized probe on the sensor surface. The dissociation phase results following the 
injection of a running buffer and non-specifically bound molecules dissociate from the 
surface. The regeneration phase proceeds with the injection of low pH buffers to remove 
bound target analytes. Following the regeneration phase the sensor response should return 
near the starting baseline signal. 
 
3. SYSTEM DESIGN 
 The sensing system consists of a commercially available surface plasmon resonance 
imaging system (iSPR, IBIS Technologies, b.v., Hengelo, The Netherlands) integrated with 
a LOC system with multiple sample inlets and outlets and electrodes for electrokinetic 
fluidic transport. Figure 1(a) shows a schematic of an integrated system. 
 
The schematic of the LOC system is shown in Figure 2(a). The microfluidic layer consists 
of an interaction chamber that is interconnected with three inlets I1-I3 for a buffer solution, 
samples and reagents. The outlet is to remove waste (W) following an analysis operation. 
The microarray layer consists of gold regions, aligned to the interaction chamber of the 
microfluidic layer. The gold sensing surface can be a continuous layer or patterned regions 
as shown in figure 2a. For multi-analyte sensing applications each gold region can consist 
of a different immobilized probe and necessary experimental controls. Different methods 
are available for probe immobilization including non-contact protein printing [3] or in-situ 
immoblization using microfluidic networks [4]. 
 
4. MICROFABRICATION 
 The biochip consists of two layers, as shown figure 2(b). The top layer is made of 
poly di-methyl siloxane (PDMS) (Sylgard 184, Dow Corning, USA) that contains the 
channel structures, interaction chamber, inlets and outlet. The SPR gold was deposited on 
the bottom layer that consists of AF45 glass refractive index (n=1.52) matched to the 
hemispherical prism. The microfabrication is performed in two separate processes. The 
PDMS layer is fabricated using a silicon wafer with patterned SU-8 (MicroChem 
Corporation, USA) structures to form the microfluidic structures. The lower microarray 
layer consists of gold islands for SPR imaging formed using a conventional lift-off 
procedure. The two layers are finally aligned and bonded with the aid of oxygen plasma 
activated surfaces. In the case that the probe molecules are first immobilized on the gold, 
then only the top microfluidic layer surface is treated with the oxygen plasma activation 
step. 
 
5. RESULTS AND DISCUSSION 
The microfabricated biochip was placed in a custom fixture with 10 µL cuvettes directly 
coupled to the inlet ports. The glass microarray layer was then placed in direct contact with 
the hemispherical prism of the SPR imaging system. Fluidic control is performed using 
electroosmotic flow with Pt wires immersed in the solution and connected to a high voltage 
power supply. The applied voltages were controlled with a LabView program. To 
demonstrate the concept 1mg/mL human IgG probe molecules are loaded into the sample 
 
 
Figure 3. (a) Three step process for i: probe immobilization, ii: surface cleaning with buffer, and 
iii: antibody-antigen interaction. (b) SPR image of our chip with 24 gold islands; (c) Sensorgram 
of 24 human IgG and anti-human IgG interactions using EOF. 
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cuvette. The probes are then transported to the interaction chamber by applying 100 V 
between inlet port I1 and the exit port W. The antigens are immobilized by direct 
adsorption onto the gold surfaces. The second inlet reservoir I2 is then filled with PBS 
buffer (pH 7.2) and transported through the system. The 10 mg/mL anti-human IgG is then 
loaded into inlet I3 and transported to the immobilized probes electroosmotically with an 
applied voltage of 50 V. The general procedure is shown in figure 3(a). The real-time 
biomolecular interaction was measured by SPR imaging, shown in figure 3(b) and (c). We 
were able to control the flow of anti-IgG over the IgG patterned gold islands in the biochip 
and detect the binding of anti-IgG to the immobilized IgG on the gold islands with SPR 
imaging. 
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